ROYAL BANK OF CANADA - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 64 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$108,000
+33.3%
36,200
-33.2%
0.00%
Q2 2016$81,000
-62.5%
54,210
-6.9%
0.00%
Q1 2016$216,000
+380.0%
58,247
+1187.2%
0.00%
Q4 2015$45,000
-75.7%
4,525
-53.5%
0.00%
Q2 2015$185,000
-94.6%
9,739
-94.0%
0.00%
-100.0%
Q4 2014$3,412,000
-37.2%
162,936
+0.0%
0.00%
-50.0%
Q3 2014$5,437,000
+7.7%
162,857
+3.5%
0.00%
+33.3%
Q2 2014$5,048,000
+26468.4%
157,318
+39229.5%
0.00%
Q1 2014$19,000
+1800.0%
400
+2400.0%
0.00%
Q4 2013$1,000
-99.8%
16
-99.7%
0.00%
Q3 2013$466,000
-86.7%
5,438
-90.2%
0.00%
-100.0%
Q2 2013$3,502,00055,2890.00%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Perceptive Advisors 4,656,682$399,310,00016.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,300,000$111,475,0005.48%
ADVENT INTERNATIONAL, L.P. 705,300$60,479,0005.01%
Antipodean Advisors LLC 266,400$22,844,0002.38%
KINGDON CAPITAL MANAGEMENT, L.L.C. 489,181$41,928,0002.06%
HealthCor Management, L.P. 425,000$36,444,0001.95%
Cupps Capital Management, LLC 290,489$24,909,0001.62%
Zweig-DiMenna Associates LLC 421,400$36,135,0001.46%
SABBY MANAGEMENT, LLC 259,119$22,209,0001.44%
Independence Capital Asset Partners, LLC 98,070$8,410,0001.43%
View complete list of AEGERION PHARMACEUTICALS INC shareholders